Strathprints logo
Strathprints Home | Open Access | Browse | Search | User area | Copyright | Help | Library Home | SUPrimo

Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebovascular hyperfusion in adult male wistar rats

van Donkelaar, Eva and Dawson, Neil and Kelly, Paul A.T and Blokland, Arjan and Prickaerts, Jos and Steinbusch, Harry WM and Ferrington, Linda (2010) Acute tryptophan depletion potentiates 3,4-methylenedioxymethamphetamine-induced cerebovascular hyperfusion in adult male wistar rats. Journal of Neuroscience Research, 88. pp. 1557-1568. ISSN 0360-4012

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

The serotonergic (5-hydroxytryptamine; 5-HT) dysfunction found in depression may affect not only brain function (mood) but also cerebrovascular control. Similar, but possibly occult, disturbances may also be induced by 3,4-methylenedioxymethamphetamine-induced neurotoxicty (MDMA, or “ecstasy”). Acute tryptophan depletion (ATD) is widely used to identify vulnerability to depression, and we hypothesized that repeated MDMA administration would increase the sensitivity of rats to this acute serotonergic challenge. In this study, male Wistar rats were injected with MDMA (20 mg · kg−1, twice daily for 4 days) and challenged 3 weeks later with ATD, induced by intragastric administration of a nutritional mixture with tryptophan (TRP) removed. Cerebral metabolism (CMRG) and blood flow (CBF) were measured in parallel groups of animals following ATD by using quantitative [14C]2-deoxyglucose and [14C]iodoantipyrine autoradiographic techniques, respectively. A significant reduction in paroxetine binding to 5-HT transporter sites in MDMA-treated rats indicated 5HT terminal depletion, whereas the plasma TRP/sum large neutral amino acids ratio was reduced by 40% following ATD. Under all experimental conditions, the normal close correlation between CBF and metabolic demand was maintained. However, a global analysis of all brain regions revealed a significant decrease in the overall ratio of CBF to CMRG after ATD in control animals, whereas a higher ratio was observed after ATD in the MDMA-treated group. This increase in blood flow relative to cerebral metabolism suggests an ATD-induced loss of cerebrovascular tone in MDMA-treated animals that could have pathophysiological consequences and might conceivably contribute to the behavioral dysfunction of depression.

Item type: Article
ID code: 36246
Keywords: neuroscience, cerebrovascular control , depression, numerical modelling, ecstacy, serotonin, plasma tryptophan, Therapeutics. Pharmacology, Cellular and Molecular Neuroscience
Subjects: Medicine > Therapeutics. Pharmacology
Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Related URLs:
    Depositing user: Pure Administrator
    Date Deposited: 01 Dec 2011 14:12
    Last modified: 05 Sep 2014 14:07
    URI: http://strathprints.strath.ac.uk/id/eprint/36246

    Actions (login required)

    View Item